In the rapidly evolving medical technology industry, staying on top of growth strategies, including mergers and acquisitions (M&A)-related transaction activity, is not just an advantage, it’s a necessity.
For Avanos Medical, one of the leading medical technology companies, the challenge was clear. It’s about streamlining corporate development and strategy workflows to drive innovation and stay competitive. What are the obstacles? A piecemeal approach to market intelligence delayed decision-making and obscured valuable insights.
Avanos’ strategy team needed comprehensive and timely market data, including private market insights, and needed to quickly navigate vast amounts of information across news, research, filings, and records. The fast pace of change in industry, news, and technology means dealmakers need to consume far more data, analyze it faster, and make accurate strategic and M&A decisions.
Navigating complex data
MedTech companies struggled with disparate data sources that took time to integrate. This fragmentation of data sources has slowed market analysis and made it difficult to identify viable investment opportunities and partnerships, especially in the private market. This often resulted in missed opportunities and postponed or delayed strategic decisions.
“It’s always difficult to find information about companies in niche and emerging markets,” says David Morhinweg, director of corporate development at Avanos Medical. Both size and growth. ”
Insights at every data point
To address these challenges, Avanos has implemented a robust solution that provides detailed market commentary and comprehensive data coverage. Avanos selects products from companies that continually invest in development to give users quick and easy access to relevant insights.
Avanos also gained workflow benefits. The Corporate Development and Strategy team transformed the company’s workflow with three key improvements:
1. New and detailed private market insights: Access to extensive private market data has enabled the company to discover and evaluate potential investment opportunities and partnerships that have previously gone unnoticed. This new capability allows Avanos to expand its reach and tap into emerging technologies and start-ups in the MedTech space.
2. Collaboration tools: The solution’s AI-powered document viewer tool streamlines the data analysis process by enabling teams to view and annotate multiple documents in the platform and discover insights faster. has been streamlined. Teams also started using advanced charting and forecasting tools, a robust Excel plug-in tool, and a library of over 550 templates to help shorten review cycles and improve collaboration to improve strategic decision-making. Enhanced.
3. In-depth aftermarket research: Using advanced tools for investment and aftermarket research, Avanos has gained insight into market trends, competitor activities, and potential risks. This comprehensive data supports more accurate forecasts and investment strategies that align with long-term business goals.
strategic leap
It’s hard to find a solution with high-quality information in an easy-to-use platform, but Avanos has it.
“With our new market map for the healthcare target market, we can now quickly identify key players, and visuals make it easier to see deal trends across M&A and private financing,” Mornhinweg said. says.
“Using Document Viewer has saved us a lot of time,” he says. “For example, when I open a transcript, I can now get a high-level overview before digging into the text. I can also see all the companies mentioned, so I can see important relationships, partnerships, growth areas, etc. Understand risk areas.”
The integration of this solution, S&P Capital IQ Pro, revolutionizes Avanos’ market analysis and investment strategy workflow. By integrating private markets, document viewers, and investment/aftermarket research capabilities into your workflow, you can now:
• Significantly reduces the time spent collecting and analyzing data, allowing strategy teams to focus on higher-value activities.
• Improved accuracy of market forecasts and strategic decisions, leading to successful investments and partnerships.
• Collaboration and information sharing among team members is enhanced, promoting a culture of informed decision-making and proactive strategy development.
Avanos Medical has transformed its corporate development and strategy workflows by integrating industry-leading market intelligence platforms to help teams navigate complex data environments. By streamlining market analysis and enhancing collaboration, Avanos is delivering better, faster, better-informed, and more strategic solutions to drive innovation and take advantage of new opportunities in medical technology. Now you can make informed decisions. This strategic leap will enable Avanos to secure sustainable growth and competitive advantage in a rapidly evolving market.
Many other sectors can also benefit from similar technology to enhance data-driven decision-making processes. As industries increasingly rely on timely insights to navigate the competitive environment, implementing advanced analytics solutions will be critical to maintaining a strategic advantage.
Learn more about S&P Capital IQ Pro.
